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Conclusions. We propose that this family represents a newFamilial nephropathy differing from minimal change nephrop-
familial nephropathy. The molecular basis of the permeabilityathy and focal glomerulosclerosis.
defect remains to be identified.Background. Nephrotic syndrome in childhood is mainly
due to minimal change nephropathy. In general, it is character-
ized by selective proteinuria, by steroid responsiveness, and
histologically by podocytic foot process effacement. Familial
Nephrotic syndrome in childhood is most commonlypresentation is rare and mainly restricted to one generation.
caused by minimal change nephropathy [1]. The termMethods. We describe the occurrence of a familial nephrop-
athy in a mother and two daughters. An initial diagnosis of mini- minimal change nephropathy is applied because of the
mal change nephropathy was made, but subsequently unique absence of glomerular abnormalities in light microscopy.
features became apparent. During follow-up, detailed studies However, on more detailed examination by electron mi-of renal function and urinary protein excretion were performed.
croscopy, alterations of the glomerular visceral epithelialAvailable frozen renal biopsy material was revised and proc-
essed for immunofluorescence to detect abnormalities in the cells are apparent in the form of effacement of the foot
expression of heparan sulfate proteoglycans. The latter results processes. It has been suggested that proteinuria in pa-
were compared with renal biopsies of a control group com- tients with minimal change nephropathy is the conse-
posed of five adult patients with minimal change nephropathy.
quence of a loss of negative charges in the glomerularResults. The mother and two daughters were proteinuric since
capillary wall [1]. Clinically, patients with minimal changetheir early childhood. The mother revealed a persistent neph-
rotic syndrome for more than 20 years despite treatment with nephropathy present with a selective proteinuria, that
various immunosuppressive drugs. Likewise, treatment with is, there is a preferential loss of the negatively charged
prednisone was ineffective in the daughters. All three patients
albumin when compared with immunoglobulin G (IgG).retained normal renal function during follow-up. Detailed mea-
Most patients quickly respond to treatment with cortico-surements revealed that the proteinuria was incredibly selective
(selectivity index ,0.01), and there was no evidence of tubulo- steroids, and even if left untreated, spontaneous remis-
interstitial damage, as reflected by a normal excretion of the sions of proteinuria do occur and the prognosis is good
low-molecular weight proteins b2-microglobulin and a1-micro- [1, 2]. After years of follow-up, proteinuria disappears,globulin. Renal biopsy performed in the mother and one daugh-
and few patients, if any, develop renal insufficiency. Fa-ter was thought to be compatible with minimal change nephrop-
milial occurrence of minimal change nephropathy hasathy. However, histologically, two remarkable findings were
made. By electron microscopy, there was no evidence of foot been reported regularly, although in most families, the
process retraction; specifically, the foot process width and slit nephrotic syndrome is restricted to one generation [3, 4].
pore diameter were normal. Furthermore, in contrast to the
The present study describes a mother and two daugh-control patients, the expression of heparan sulfate polysaccha-
ters, all three of whom developed a nephrotic syndromeride side chains, as reflected by the staining with monoclonal
antibody JM403, was normal. during early childhood. Clinical and histologic features
initially suggested a diagnosis of minimal change nephrop-
athy. However, several arguments favor the idea that
these patients represent a new syndrome. First, the ne-
Key words: glomerular permeability defect, progressive renal injury,
phrotic syndrome was present in two generations; sec-inherited kidney disease, steroid-resistant proteinuria, podocyte foot
process, heparan sulfate. ond, proteinuria was highly selective; third, the nephrotic
syndrome was treatment resistant and persisted for more
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she was pregnant three times. During these pregnancies,
she had to be treated with methyldopa and chlorthali-
done because of a slight rise in blood pressure to maxi-
mum levels of 150/60 mm Hg. No increase of proteinuria
was observed, and renal function remained normal. She
gave birth to two daughters and one son, all born at
term. Renal biopsies were performed in 1971, 1973, and
1978 (discussed later in this article). Detailed studies of
renal function and urinary protein excretion were done
in 1996 and were repeated three years later (discussed
later in this article).
Case 2: The oldest daughter. In this girl, proteinuriaFig. 1. Time course of serum albumin ( ) and 24-hour urinary protein
excretion (s) in patient 1. Serum albumin levels have been persistently was diagnosed in 1979 in the first year of her life. In
below 30 g/L. Urinary protein levels measured in spot urines are not 1991, at the age of 12, she was sent to a pediatrician by
shown (discussed in the text).
her family doctor because of persistent asymptomatic
proteinuria. The proteinuria was in the nephrotic range
(4.6 to 4.9 g/L) and accompanied by hypoalbuminemia
ment membrane heparan sulfate polysaccharide side (range 27 to 31 g/L) and hypercholesterolemia (.8
chains, which are thought to play an important role in mmol/L). Treatment with high-dose prednisone (45 mg
the charge-selective properties of the glomerular capil- daily for more than 8 weeks) was started. However, the
lary wall [5, 6]. We propose that this familial nephropathy therapy was ineffective, and it was decided to perform
represents a new entity. The pathogenetic mechanism a renal biopsy (discussed later in this article). Subse-
involved in the glomerular permeability defect remains quently, in 1992, she was treated with a course of cyclo-
to be identified. phosphamide (2 mg/kg for 8 weeks). Again, the patient
did not respond to this treatment. Because of the similar-
Case histories
ity in presentation between the daughter and the mother,
Case 1: The mother. Severe proteinuria was discov- who had a favorable course, it was decided not to do
ered in the mother in 1964, at the age of seven years, more interventions. Since 1995, the patient has been seen
during investigations because of pretibial edema. Her yearly by the same nephrologist who treated her mother.
blood pressure was normal, and the urinary sediment Laboratory examinations revealed average serum albu-
revealed no abnormalities. From 1966 to 1981, several min levels of 29 g/L (range 28 to 30 g/L) and proteinuria
efforts to reduce the proteinuria were unsuccessful. In of 2.3 g/24 hours (range 2.0 to 2.6 g/24 hours). Blood
this 15 year period, the patient was intermittently treated
pressures have always been low, and edema was never
with mevaquine (four months), high and low doses of
noticed. Detailed clinical studies were done in 1996 andprednisone and indomethacin for several years, a combi-
1999.nation of chlorambucil and 6-mercaptopurine for three
Case 3: The youngest daughter. In this patient, bornmonths, and two separate courses of cyclophosphamide
in 1982, proteinuria was also first noted in the year after(3 and 4 months, respectively). Throughout these years,
her birth. In 1991, she went together with her older sis-she was regularly seen at the outpatient clinic, and the
ter to the pediatrician. Similar to her mother and sister,records show that the proteinuria persisted despite these
she also had repeatedly elevated cholesterol levelstreatment efforts. Urinary protein levels measured in
(.8 mmol/L) and hypoalbuminemia (28 to 30 g/L). Thespot urines ranged from 1.1 to 12.4 g/L, the variability
proteinuria averaged 4.2 g/24 hours during measure-most likely reflecting differences in urinary flow rate.
ments in 1991. Also, she was treated unsuccessfully withWhenever measured in urine samples collected over 24
high-dose prednisone. A renal biopsy was not performedhours, proteinuria exceeded 3.5 g/24 hours (Fig. 1). Most
because of the known abnormalities in her mother andimportant, hypoalbuminemia was present at all times,
sister. From 1995 onward, she has visited the nephrolo-indicative of a persistent nephrotic syndrome (average
gist yearly at the outpatient clinic. She infrequently ob-value 23 6 2 g/L, range 19 to 27 g/L, N 5 66; Fig. 1).
served edema in her hands, but most of the time she wasFrom 1966 onward, increased levels of total cholesterol
asymptomatic. Serum albumin levels averaged 29 g/L(.10 mmol/L) were reported. Because of the latter, since
(range 28 to 30 g/L), and proteinuria averaged 4.5 g/241982, treatment was started with cholestyramine and
hours (range 4.2 to 4.8 g/24 hours). We studied this pa-after several years this was changed to simvastatin. In
tient when she accompanied her family members in 19961990, she was supplemented with levothyroxine because
of hypothyroidism. In the period between 1978 and 1983, and 1999.
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METHODS this lowest measurable value of 2 mg/L, and the results
are expressed as “lesser than.”Clinical studies
Clinical studies were performed according to a stan- Processing of the renal biopsies
dard protocol. The measurements were carried out in
For light microscopy (LM), a portion of the kidney bi-the morning after an overnight fast. The evening before
opsy was fixed in Bouin’s solution, dehydrated, and em-the study day the patients took 4000 mg of sodium bicar-
bedded in paraplast (Amstelstad, Amsterdam, The Neth-bonate to ensure a urinary pH above 6.0, which is needed
erlands). Two micrometers sections were stained withto prevent degradation of b2-microglobulin. For the stud- hematoxylin eosin, periodic acid-Schiff (PAS), and silveries performed in 1999, the patients also received 1200 mg
methenamine. For immunofluorescence (IF), kidneyof cimetidine in the morning in order to block tubular se-
fragments were snap frozen in liquid nitrogen, and 2 mmcretion of creatinine [7]. Upon arrival at the ward, the pa-
cryostat sections were incubated with fluorescein-labeledtients received 375 to 500 mL of tap water to enforce diur-
antisera directed to human IgG, IgM, IgA, C1q, C3, andesis. The patients remained supine during two hours, ex-
fibrinogen (Dako, Copenhagen, Denmark). For electroncept for voiding. Timed urine samples were collected, and
microscopy (EM), a small piece of the biopsy was fixedin the middle of the collection period, a blood sample was
in 2.5% glutaraldehyde dissolved in 0.1 mol/L sodiumdrawn. Blood and urine samples were used to determine
cacodylate buffer, pH 7.2, for four hours at 48C andcreatinine, the low molecular weight proteins b2-micro-
washed in the same buffer. The tissue fragments wereglobulin and a1-microglobulin, the enzyme b-N-acetyl-
postfixed in phosphate-buffered 2% OsO4 for two hours,glycosidase (bNAG), and the middle and high-molecular-
dehydrated, and embedded in Epon 812. Ultra-thin sec-weight proteins albumin, transferrin, and IgG. Blood
tions were cut in an ultratome (LKB Producteer, Bromma,pressure was recorded using an automatic device (Dina-
Sweden) and stained with 5% uranyl acetate for 45 min-map), ten consecutive readings being done at five-minute
utes and with lead citrate for two minutes at room temper-intervals. In addition to the timed urine samples, the
ature. The sections were examined using a JEOL 1200patients also collected 24-hour urine samples for deter-
EX2 electron microscope (JEOL, Tokyo, Japan).mination of creatinine, sodium, and total protein.
Detailed morphometric measurements of the glomer-
ular basement membrane (GBM), the podocytic footLaboratory procedures and calculations
processes and the slit-pore diaphragm were done onThe concentrations of creatinine, sodium, cholesterol,
high-power micrographs of EM pictures. The foot proc-and urinary total protein were measured with standard
ess width was determined on 375,000 power micro-automated techniques. The concentrations of albumin,
graphs as described [13, 14]. In brief, the number of foottransferrin, a1-microglobulin, and IgG in serum and urine
processes overlying the capillary basement membranewere measured by immunonephelometry using antibod-
was counted and divided by the length of the particularies in which the specificity was checked by Ouchterlony
segment of the capillary basement membrane. A correc-double immunodiffusion and immunoelectrophoresis.
tion factor of p/4 was used as recommended in the litera-Details of these nephelometric procedures have been de-
ture [13]. For these measurements, five random openscribed before [8, 9]. Urinary b2-microglobulin was mea-
capillary loops were used with a total GBM length of ap-sured by an enzyme-linked immunosorbent assay (ELISA)
proximately 100 mm. The thickness of the GBM wasmethod [10].
measured on 315,000 power micrographs [15]. A totalCreatinine clearance was estimated from the Cock-
of 50 measurements in five loops was done. The slit-porecroft and Gault formula. In the 1999 studies, renal func-
diaphragm was measured on 375,000 power micro-tion was assessed by calculating the creatinine clearance
graphs. The width was measured on the level of the slit(CCr), measured after administration of cimetidine, by
membrane or at the narrowest point. An average of fiveusing the formula (UCr 3 V)/PCr, where UCr is the concen-
to eight slit pores was used for the measurements.tration of creatinine in the urine, V is the urine flow
and PCr is the plasma concentration of creatinine. Since
Immunofluorescence studies of heparancimetidine blocks the tubular secretion of creatinine, the
sulfate proteoglycanscreatinine clearance measured during cimetidine admin-
To assess heparan sulfate proteoglycan (HSPG) stain-istration closely reflects the glomerular filtration rate
ing of the GBM, the following antibodies were used (Table[11, 12]. The mean arterial pressure was the average
1): (1) goat polyclonal antibody Bl31; (2) mouse IgG1of ten registered measurements. The protein selectivity
monoclonal antibody (mAb) JM72, both directed againstindex was calculated as the clearance of IgG divided by
the core protein of agrin, which is the major HSPG inthe clearance of albumin. In cases with IgG levels in
the GBM [16, 17]; (3) mouse IgM mAb JM403, whichurine below the detection limit of 2 mg/L, the selectivity
index and urinary excretion of IgG were calculated using recognizes a low-sulfated domain within the heparan sul-
Branten et al: Familial nephropathy696
Table 1. Antibodies used for immunohistochemistry
Primary antibody Secondary antibody
Antigen Code Ref. Dilution Code Supplier Dilution
Agrin core JM72 [17] 400 Sheep anti-mouse IgG-FITC Cappel 500
Agrin core BL31 [16] 400 Rabbit anti-goat IgG-FITC De Beer Medicals 500
HS JM403 [6, 18] 800 Goat anti-mouse IgM-FITC Nordic 75
HS stub 3G10 [19] 200 Goat anti-mouse IgG2b-FITC Southern 100
Abbreviations are: HS, heparan sulfate; IgG and IgH, immunoglobulin G and H, respectively; FITC, fluorescein isothiocyanate.
fate polysaccharide side chain, containing an N-unsubsti-
tuted glucosamine unit [6, 18]; and (4) mouse IgG2b
mAb 3G10, which is directed against heparitinase-gener-
ated HS stubs [19]. By heparitinase digestion, a terminal
4,5-unsaturated uronate residue is formed that is essen-
tial for recognition by 3G10. The staining of 3G10 can
serve as a general HS marker, independent of the extent
of HS modification.
Indirect IF was performed as described before on 2 mm
cryostat sections of kidney tissue [20]. Sections were
fixed in acetone at 48C during 10 minutes (except for
the sections that were digested by heparitinase before
Fig. 2. Pedigree of the family. The proteinuric members are depicted
staining with mAb 3G10). Primary and secondary anti- with closed symbols. Number II-1 represents our index patient (case
1). Numbers III-1 and III-3 are her proteinuric daughters (cases 2 andbodies (Table 1) were diluted in phosphate-buffered sa-
3). The open symbols represent family members without proteinuria.line (PBS) containing 1% bovine serum albumin (BSA)
The urine of one nonrelative case was not tested (crossed symbol).
and 0.05% sodium azide (IF buffer) and incubated for
30 minutes at room temperature. After incubation with
antibodies, the sections were washed in PBS and embed- calculations of the protein selectivity index; however, as
ded in Aquamount (pH 7.0; BDH, Poole, UK) and exam- indicated even when using the lowest detection level of
ined with a Zeiss Axioskop microscope with an epi- 2 mg/L for urinary IgG, proteinuria was highly selective.
illuminator. For 3G10 staining, nonfixed sections were Exact calculation of the selectivity index was possible in
incubated with 0.25 U/mL heparitinase (heparan sulfate the 1999 samples of the mother and yielded a value as
lyase III; Sigma, St. Louis, MO, USA) in 10 mmol/L low as 0.01. In daughter 1, we noticed a discrepancy in
HEPES and 2 mmol/L CaCl2, pH 7.0, for one hour at albuminuria in the timed urine sample compared with
378C. Negative controls include the whole IF procedure the proteinuria measured in the 24-hour urine. This dif-
without the incubation of the primary antibodies. All ference in quantity suggested that the proteinuria in this
controls were negative. patient partially was orthostatic. To exclude the presence
of mere orthostatic proteinuria, all three family members
subsequently collected urine samples separately duringRESULTS
the day and night. Also, in the overnight urine collec-
A pedigree of the family is depicted in Figure 2. Pro- tions, overt proteinuria was observed with protein:creati-
teinuria was only detected in the mother and her two nine ratios of 6.0 g/10 mmol (vs. 12.2 g/10 mmol at day-
daughters. The parents of the mother, a brother and his time) in the mother, 1.2 g/10 mmol (vs. 3.2 g/10 mmol
daughter, and a son all tested negative. In the family’s at daytime) in the eldest daughter, and 4.1 g/10 mmol
history, there was no mention of marriages between fam- (vs. 5.3 g/10 mmol at daytime) in the youngest daughter.
ily members. We measured the urinary excretion of the low molecular
weight proteins b2-microglobulin and a1-microglobulin
Clinical studies to ascertain tubulointerstitial injury. As indicated in Ta-
The results of the clinical studies performed in 1996 ble 2, the values were normal and did not increase over
and 1999 are summarized in Table 2. All three patients the three year period.
have persistent proteinuria and a stable, normal renal
Histologic evaluation of the renal biopsiesfunction as reflected by the creatinine clearance and se-
rum b2-microglobulin. The urine mainly contained albu- The first renal biopsy of the mother was performed
min, and in most of the urine samples the levels of IgG in 1971. LM revealed 28 glomeruli that all looked normal.
In the pars convoluta of the proximal tubular cells, nu-were below the detection limit. This precluded accurate
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Table 2. Results of repeated clinical studies in the mother and her two daughters
Mother Daughter 1 Daughter 2
Normal
1996 1999 1996 1999 1996 1999 range
Age years 39 42 17 20 14 17
Body weight kg 48.5 56.2 47 53.7 58.9 66.3
MAP mm Hg 90 90 81 72 83 90
Serum levels
Creatinine lmol/L 41 54 39 52 40 55 50–90
Albumin g/L 22 24 27 31 30 35 40–50
Cholesterol mmol/L 8.0 11.2 6.8 7.4 8.1 8.2 4.7–6.5
LDL mmol/L 5.29 7.8 4.54 5.43 5.64 5.40 ,4.7
b2m mg/L 1.31 1.36 1.09 1.20 1.05 1.17 1.0–2.0
ECC mL/min/1.73 m2 149 119 185 144 205 152 80–150
GFR mL/min/1.73 m2 84 112 86 80–130
Urinary excretion
Total protein lg/min 2848 3241 250 603 1246 3211 ,100
Albumin lg/min 2497 2237 184 358 1057 2248 ,20
IgG lg/min ,13.2 9.1 ,2.6 ,3.8 ,5.4 ,10.7 ,10
Transferrin lg/min 152 192 13.1 32 84 155 ,2
b2m ng/min 66 50 38 41 87 91 ,200
a1m lg/min 13.2 9.1 2.6 5.7 8.1 ,10.7 ,10
Selectivity index ,0.02 0.01 ,0.08 ,0.02 ,0.06 ,0.02
Proteinuria g/24 h 4.6 5.7 2.0 2.7 3.3 4.3 ,0.2
Abbreviations are: MAP, mean arterial pressure; b2m, b2-microglobulin; a1m, a1-microglobulin; ECC, endogenous creatinine clearance calculated with Cockcroft
formula; GFR, glomerular filtration rate reflected by the creatinine clearance after cimetidine (Methods section).
Table 3. Histomorphometric data
Biopsy 1973 Biopsy 1978
Biopsy Normal range
Mother daughter [14, 45]
GBM thickness nm 485 411 315 221–437
Foot process width nm 561 764 605 511–963
Slit pore diameter nm 38 37 33 35–45
GBM is glomerular basement membrane.
A description of the procedures is in the Methods section.
merous PAS-positive granules were observed, mainly GBM, and as well as normal values for both the width
of the foot processes and the diameters of the slit poresat the apical site. The remaining parts of the tubuli,
interstitium, and blood vessels did not demonstrate ab- (Table 3).
normalities. No tissue was processed for IF or EM. The
Expression of glomerular heparan sulfate proteoglycansecond biopsy (22 glomeruli) and third renal biopsy (15
glomeruli) performed in 1973 and 1978, respectively, To study the expression of HSPG in renal tissue, we
used various antibodies recognizing different domainsshowed similar morphology as the first biopsy by LM,
that is, normal-looking glomeruli and no fibrosis in the of the HSPG molecule, including a mAb against the
HS polysaccharide side chains. Since no renal tissue wasinterstitium (Fig. 3A). Minor (11) mesangial IgM depos-
its were seen by IF (4 glomeruli). By EM (3 glomeruli), available for the daughter, these studies could only be
done on renal tissue of the mother. For comparison, weno retractions of the foot processes could be observed
in both biopsies (Fig. 3B). The biopsy of the daughter, processed simultaneously renal tissue from five adult pa-
tients with a nephrotic syndrome and minimal changeperformed in 1991, revealed 19 glomeruli by LM exami-
nation and disclosed findings similar to the three biopsies nephropathy. In our patient, we observed a normal, un-
changed linear staining of the GBM with both antibodiesof the mother as shown by LM, IF, and EM. Thus, in
the daughter, granules in tubular cells also were present against agrin core protein (BL31 and JM72). Barely any
staining was observed in the mesangial regions (Fig. 4B).as a sign of protein reabsorption. No foot process retrac-
tion was observed by EM, and IF showed mild IgM These results are in agreement with our previous findings
in normal human renal tissue [16, 17]. Staining with mAbdeposits in the mesangium.
Detailed morphometric measurements of two biopsies 3G10 revealed a linear staining of the GBM, including
staining of the mesangium in accordance with earlier find-of the mother and of the biopsy performed in the oldest
daughter revealed normal values of the thickness of the ings. This indicates that in this patient glycanation (the
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Fig. 3. Light and electron microscopic pic-
tures of the third biopsy of the mother. (A)
Normal-looking glomerulus, methenamine sil-
ver staining, 3350. (B) Electron microscopy of
a part of a capillary loop. The foot processes of
the podocytes reveal no retraction, 312,000.
Fig. 4. Immunofluorescence of the third biopsy
of the mother (A and B) and a biopsy of a
patient with classical minimal change ne-
phropathy (C and D). Unchanged presence
of (A) heparan sulfate side chains as detected
by monoclonal antibody (mAb) JM 403, and
(B) core protein as demonstrated by mAb JM
72 of heparan sulfate proteoglycan (HSPG)
along the capillary loops. In the biopsy of a
patient with classical minimal change ne-
phropathy, the heparan side chains have com-
pletely disappeared (C), while staining of the
core protein of HSPG is normal (D, 3600).
addition of HS side chains) of the HSPG core protein staining with both antibodies against the agrin core pro-
tein (Bl31 and JM72) as well as with 3G10 against theproceeded normally. Staining of the HS side chains using
mAb JM403 revealed a linear staining of the GBM that HS stubs was observed (Fig. 4D). However, the staining
for HS with mAb JM403 was almost completely absentwas not discernible from normal renal tissue (Fig. 4A).
These data show a strictly normal distribution of the in three patients and was reduced for about 50 and 80%
in the other two patients (Fig. 4C). This is in contrast tovarious antibodies against GBM HSPG and indicate no
changes in HSPG expression in our patient. our patient who did not show any reduction in GBM
HS staining.In renal biopsies of the five control patients, normal
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DISCUSSION a cluster of related diseases [1, 29, 30]. The debate on
whether these diseases are separate entities will probablyThis study describes the occurrence of a nephrotic
continue until the pathogenesis of these glomerular dis-syndrome in a mother and her two daughters. This family
orders is unraveled at the molecular level.most likely represents a new syndrome with the following
In our patients, the proteinuria was highly selective;characteristics: the presence of proteinuria in two consec-
in fact, the value of 0.01 in the mother is the lowestutive generations, normal glomeruli as shown by LM,
value we have ever observed in a patient with nephrotichighly selective steroid-resistant proteinuria, an absence
syndrome. Selective proteinuria is indicative of a prefer-of effacement of the podocytic foot processes, and nor-
ential loss of albumin. Theoretically, preferential loss ofmal expression of heparan sulfate side chains.
albumin might be the result of an abnormal charge ofInitially a diagnosis of minimal change nephropathy
the albumin. We excluded this possibility by testing urinewas made in these patients. The presentation at early
and serum samples of the mother by agarose-electropho-childhood, selective proteinuria, and the light microscop-
resis. The increased protein loss in our patients mayical finding of normal glomeruli were compatible with
result from alterations in any of the components thatsuch a diagnosis. Unexpectedly, the nephrotic syndrome
constitute the glomerular filtration barrier. The highlydid not respond to treatment with steroids or other im-
selective proteinuria observed in our patients is generallymunosuppressive drugs. Few patients, if any, with classic
considered to reflect a defect in glomerular charge selec-“minimal change nephropathy” are treatment resistant.
tivity [31, 32]. The polyanionic coat of the glomerularIn such cases, a diagnosis of focal glomerulosclerosis
epithelial cells and particularly the negatively charged(FGS) is most likely, and the typical lesions of FGS
heparan sulfate side chains in the GBM are the mainare usually demonstrated in follow-up biopsies [21, 22].
constituents of the glomerular wall negative charge. Re-Admittedly, even the absence of such lesions in the third
moval of sialic acid from the glomerular epithelial cellsbiopsy of our first patient does not definitely exclude the
causes foot process fusion [33, 34]. Thus, foot processpossibility of FGS; however, the clinical course in our
effacement may reflect loss of glomerular epithelial cell
patient clearly argues against such a diagnosis, since pa-
polyanion. In our patients, podocytic foot processes were
tients with treatment resistant FGS usually progress to not retracted, suggesting that the polyanion charge of
renal failure. Most important, the finding of normal foot the visceral epithelial cells has remained unaltered. We
processes is a remarkable observation, as effacement of also found no evidence for changes in HSPGs, which
the podocytic foot processes is a characteristic finding supposedly are involved in minimal change nephropathy
in patients with minimal change nephropathy, as well as [20]. Our patient demonstrated normal staining with
in patients with idiopathic FGS [23, 24]. JM403, a mAb directed to the negatively charged he-
The occurrence of a nephrotic syndrome within a fam- paran sulfate polysaccharide side chain. This finding
ily is not unusual. About 3.4% of European children clearly separates the disease in our patient from minimal
with minimal change nephropathy have affected siblings change nephropathy, since all patients in our control
[3]. However, in most families, the disease is confined group showed the loss of heparan sulfate and fusion of
to one generation. In one of the most extended overviews podocytic foot processes. Overall, there was no evidence
of familial nephrotic syndrome, 58 affected families were of abnormalities in the best known negatively charged
studied [3]. Only one of these families had proven ne- components of the glomerular filter. Obviously, we can-
phrotic syndrome in two consecutive generations, a fa- not exclude the presence of structural abnormalities of
ther and daughter who developed proteinuria at the age heparan sulfate side chains or damage of other charged
of seven and two years, respectively. As expected in molecules.
patients with minimal change nephropathy, their ne- Recently, major progress has been made in identifying
phrotic syndrome responded to treatment with steroids. proteins involved in maintaining the integrity of the slit
Familial FGS has also been described, and recently link- pore diaphragm. One key component is nephrin, and
age to both chromosome 19 and 11 has been suggested mutations in the nephrin gene on chromosome 19 are
[25, 26]. In familial FGS, two generations are more fre- held responsible for the congenital nephrotic syndrome
quently involved. Clinically, familial FGS is character- of the Finnish type [35, 36]. Animal studies have indi-
ized by steroid resistance and progression toward end- cated that proteins associated with nephrin such as CD2-
stage renal disease [27, 28]. Finally, two families have associated protein (CD2AP) may also play a role [37].
been reported in whom IgM nephropathy occurred in CD2AP knockout mice develop proteinuria and EM
two generations [29]. In both families, the disease ran a shows effaced foot processes [37]. The finding of a nor-
progressive course with the development of renal failure, mal slit-pore width and the presence of normal foot proc-
thus bearing striking similarity with the described cases esses in our patients argues against abnormalities in
of familial FGS. Some authors consider minimal change nephrin, CD2AP, or other proteins involved in the slit
diaphragm.nephropathy, FGS, and IgM nephropathy to be part of
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